BRAUNWALD
ET AL., MANAGEMENT OF PATIENTS WITH UNSTABLE ANGINA AND NON-ST-SEGMENT
ELEVATION MYOCARDIAL INFARCTION UPDATE
http://www.acc.org/clinical/guidelines/unstable/incorporated/index.htm
ACC/AHA
2002 Guideline Update for the Management of Patients With Unstable
Angina and Non-ST-Segment Elevation Myocardial Infarction
A
Report of the American College of Cardiology/American Heart Association
Task Force on Practice Guidelines (Committee on the Management of
Patients With Unstable Angina)
Figures
Figure
1. Nomenclature of ACSs.
Figure 2. Schematic of the causes
of UA.
Figure 3. Unadjusted survival probability.
Figure 4. Relationship
between cardiac troponin levels and risk of mortality in patients
with ACS.
Figure 5. Plot
of the appearance of cardiac markers in blood vs. time after onset
of symptoms.
Figure 6. Algorithm
for evaluation and management of patients suspected of having ACS.
Figure 7. Acute
ischemia pathway.
Figure 8. Summary
of trials of antithrombotic therapy in UA.
Figure 9. The
use of LMWH in UA showing effects on the triple end points of death,
MI, and recurrent ischemia with or without revascularization.
Figure 10. Kaplan-Meier
curves showing cumulative incidence of death or MI in patients randomly
assigned to platelet GP IIb/IIIa receptor antagonist (bold line)
or placebo.
Figure 11. Adverse
outcome by initial ECG in ACS.
Figure 12. Revascularization
strategy in UA/NSTEMI.
Figure 13. Death
and MI at 30 days after PCI in patients with ACS.
Figure 14. Death,
MI, and urgent intervention at 30 days after PCI in patients with
ACS.
Figure 15. OR
of selected characteristics, treatment, outcome, and discharge medication
in women with unstable angina and non–ST-segment elevation MI versus
men in the TIMI III registry.
Figure 16. ORs
of selected characteristics, treatment, outcome, and discharge medications
in elderly patients (aged more than 75 years) vs younger patients
with unstable angina and non–ST-segment elevation MI in the TIMI
III registry.
Tables
Table
1. Guidelines for the Identification of ACS Patients by
ED Registration Clerks or Triage Nurses.
Table 2. Causes of UA.
Table 3. Three Principal Presentations
of UA.
Table 4. Grading
of Angina Pectoris According to CCS Classification.
Table 5. Likelihood
That Signs and Symptoms Represent an ACS Secondary to CAD.
Table
6. Short-Term
Risk of Death or Nonfatal MI in Patients With UA.
Table
7. Risk
of Death Associated With a Positive Troponin Test in Patients With
Suspected ACS.
Table
8. Risk
of Death or MI Associated With a Positive Troponin Test in Patients
With UA.
Table
9. Biochemical
Cardiac Markers for the Evaluation and Management of Patients With
Suspected ACS but Without ST-Segment Elevation on 12-Lead ECG.
Table
10. Class
I Recommendations for Anti-Ischemic Therapy in the Presence or Absence
of Continuing Ischemia or High-Risk Features.
Table
11. NTG
and Nitrates in Angina.
Table
12. Properties
of Beta-Blockers in Clinical Use.
Table
13. Properties
of Calcium Antagonists in Clinical Use.
Table
14. Class
I Recommendations for Antithrombotic Therapy.
Table
15. Clinical
Use of Antithrombotic Therapy.
Table 16. Outcome
of Death or MI in Clinical Trials of Platelet GP IIb/IIIa Antagonists
that Involve >1,000 Patients.
Table 17.
Noninvasive
Risk Stratification.
Table 18.
Noninvasive
Test Results that Predict High Risk for Adverse Outcome (LV Imaging).
Table 19. Noninvasive
Test Results that Predict High
Risk for Adverse Outcome on Stress Radionuclide Myocardial Perfusion
Imaging.
Table 20.
Mode
of Coronary Revascularization for UA/NSTEMI.
Table 21.
Medications
Used for Stabilized UA/NSTEMI.
Table 22. Clinical
Characteristics in the Typical Patient With Cocaine-Related Chest
Pain, UA or MI.
|
